Abiopharma

News list

📋 JULA INRIG (Officer) plans to sell 445 shares of TRAVERE THERAPEUTICS, INC. (at $37.75 each, total $17K) Filed: Jan 06, 2026 | ID: 000175

Full text

News bot Jan. 6, 2026, 9:14 p.m.
📋 Form 144 Filing: JULA INRIG

Company: TRAVERE THERAPEUTICS, INC.

Filing Date: 2026-01-06

Relationship: Officer
Planned Sale Details:
- Security: Common
- Shares to be Sold: 445
- Price per Share: $37.75
- Total Value: $16,798.75
- Planned Sale Date: 2026-01-06
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-36257
- Issuer Contact Phone: 888-969-7879
- Issuer Address: 3611 Valley Centre Drive, Suite 300, San Diego, CA, 92130
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 89472327.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 2
- Signature: /s/ Jula Inrig